(Q43036890)

English

Long-term treatment with the combination of amantadine and ribavirin in hepatitis C nonresponders. A case series

scientific article published on 31 March 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Long-term treatment with the combination of amantadine and ribavirin in hepatitis C nonresponders. A case series (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

author name string

Thomas R Riley

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Mohammad R Taheri

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

31 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

3418-3422

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Retreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17401686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17401686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17401686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://pubmed.ncbi.nlm.nih.gov/17401686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of relapsers after combination therapy for chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17401686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17401686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amantadine's viral kinetics in chronic hepatitis C infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17401686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of chronic hepatitis C with amantadine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17401686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amantadine therapy for chronic hepatitis C: a dose escalation study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17401686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global epidemiology of hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17401686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amantadine therapy for chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/17401686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2a in patients with chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17401686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonresponders to hepatitis C virus antiviral therapy: pegylated interferons and beyond

1 reference

https://pubmed.ncbi.nlm.nih.gov/17401686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Future trends in managing hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17401686

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-007-9762-Z

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43036890&oldid=2205761153"